Candel Therapeutics, Inc. (CADL)
Nasdaq: CADL · Biological Products, (No Diagnostic Substances) · Needham, MA · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 12, 2026 | Mar 13, 2025 | Mar 28, 2024 | Mar 30, 2023 | Mar 29, 2022 | · |
| Revenue | · | · | · | 125 | 125 | 125 |
| Research and development | 30,496 | 19,314 | 24,506 | 20,787 | 15,178 | 8,754 |
| General and administrative | 17,770 | 14,057 | 13,885 | 14,060 | 10,673 | 5,181 |
| Total operating expenses | 48,266 | 33,371 | 38,391 | 34,847 | 25,851 | 13,935 |
| Operating income | -48,266 | -33,371 | -38,391 | -34,722 | -25,726 | -13,810 |
| Interest expense | 2,119 | 2,090 | -2,595r | 1,708 | · | · |
| Interest and investment income | · | · | 2,081 | 1,218 | -53 | 111 |
| Total non-operating income (expense) | 10,084 | -21,806 | 452 | 15,928 | -10,398 | -3,870 |
| Income before income taxes | -38,182 | -55,177 | · | · | · | · |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | · |
| Net income including non-controlling interests | -38,182 | -55,177 | -37,939 | -18,794 | -36,124 | -17,680 |
| Net income | -38,182 | -55,177 | -37,939 | -18,794 | -36,124 | -17,680 |
| Earnings per share, basic | -0.72 | -1.74 | -1.31 | -0.65 | -1.91 | · |
| Earnings per share, diluted | -0.72 | -1.74 | -1.31 | -0.65 | -1.91 | · |
| Earnings per share, basic and diluted | · | · | · | · | -1.91 | -1.52 |
| Weighted average shares, basic | 52,958,644 | 31,675,076 | 28,935,289 | 28,823,480 | 18,873,048 | · |
| Weighted average shares, diluted | 52,958,644 | 31,675,076 | 28,935,289 | 28,823,480 | 18,873,048 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 18,873,048 | 11,615,208 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpense
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterest
us-gaap:InvestmentIncomeNetTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted